1 – 10 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice'
- Cessation of spread as a treatment objective in vitiligo : perception from the patients' point of view
- The many faces of IL-17 in inflammatory skin diseases
- Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread
- 2015
- Hypochromic vitiligo: delineation of a new entity
- microRNAs in psoriasis: leaders or followers?
- Relevance of congenital melanocytic naevi in vitiligo
- 2014
- Health-related quality of life in patients with melanoma expressed as utilities and disability weights
- One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis
- Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)